Research Article
Combining the Fibrinogen/Albumin Ratio and Systemic Inflammation Response Index Predicts Survival in Resectable Gastric Cancer
Table 1
Clinical and laboratory characteristics of 231 GC patients.
| | No. of patients (%) |
| | Sex | | | Male | 156 (67.5) | | Female | 75 (32.5) | | Age (years) | | | <60 | 76 (32.9) | | ≥60 | 155 (67.1) | | Neutrophils (×109/L) | | | <3 | 90 (39.0) | | ≥3 | 141 (61.0) | | Lymphocytes (×109/L) | | | <1.4 | 89 (38.5) | | ≥1.4 | 142 (61.5) | | Monocyte (×109/L) | | | <0.29 | 49 (21.2) | | ≥0.29 | 182 (78.8) | | Platelet (×109/L) | | | <237 | 135 (58.4) | | ≥237 | 96 (41.6) | | Alb (g/L) | | | <40.8 | 92 (39.8) | | ≥40.8 | 139 (60.2) | | FIB (g/L) | | | <2.79 | 91 (39.4) | | ≥2.79 | 140 (60.6) | | NLR | | | <2.14 | 111 (48.1) | | ≥2.14 | 120 (51.9) | | PLR | | | <136 | 91 (39.4) | | ≥136 | 140 (60.6) | | FAR | | | <0.071 | 112 (48.5) | | ≥0.071 | 119 (51.5) | | SIRI | | | <0.84 | 124 (53.7) | | ≥0.84 | 107 (46.3) | | Tumour location | | Upper third | 54 (23.4) | | Middle third | 53 (22.9) | | Lower third | 119 (51.5) | | Mixed | 5 (2.2) | | Tumour size (cm) | | | <3 | 86 (37.2) | | ≥3 | 145 (62.8) | | Differentiation | | | Poor | 194 (84.0) | | Moderate and well | 37 (16) | | TNM stage | | | I | 59 (25.5) | | II | 65 (28.1) | | III | 107 (46.3) |
|
|
